InVivo Therapeutics Holdings Corp (NVIVQ)

[TheHound]

wrong. the minimum bid price requirement stems from Section 5550(a)(2) of the Nasdaq's Equity Rules guide. It clearly states: "(a) Continued Listing Requirements for Primary Equity Securities: (2) Minimum bid price of at least $1 per share."

I have spent hundreds of hours over the past three years completing due diligence on Invivo Therapeutics.... It is also correct that this stock must stay at $4p/s to remain within the NASDQ listing that it currently has...